Hikma Pharmaceuticals PLC
HIK
株式のランク
#25461
Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the... Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the creation, production, promotion, and distribution of a wide array of generic, branded, and licensed medicinal solutions. These offerings are presented in various dosage formats, including solid, semi-solid, liquid, and injectable forms. The company's operations are strategically structured into three core segments: Injectables, Generics, and Branded. The Injectables division specializes in providing generic injectable medications, predominantly for hospital environments. Conversely, the Generics segment is responsible for supplying oral and other non-injectable generic pharmaceuticals to the consumer retail market. The Branded unit caters to both retail and hospital clients with its proprietary generic and in-licensed products. Hikma's comprehensive product portfolio addresses a broad spectrum of medical conditions, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory ailments. The firm boasts a substantial international presence, conducting business across the United Kingdom, the United States, the Middle East, North Africa, and various European countries. Founded in 1978, the company's corporate headquarters are situated in London, United Kingdom.
株価
$22.61
時価総額
$46.82M
変化（1日）
0.48%
変化（1年）
-52.37%
国
GB
取引 Hikma Pharmaceuticals PLC (HIK)
カテゴリー
Healthcare
の時価総額 Hikma Pharmaceuticals PLC(HIK)
時価総額: $46.82M
October 2026時点で、Hikma Pharmaceuticals PLC の時価総額は $46.82M です。これは、当社のデータによると、Hikma Pharmaceuticals PLC が世界で25461st番目に価値のある企業であることを意味します。時価総額は、上場企業の発行済株式の総市場価値であり、企業の価値を測るためによく使用されます。
Hikma Pharmaceuticals PLC の時価総額の履歴（2011 から 2026 まで）
